The alteration of aversive thresholds with cholinergic and adrenergic agents.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D003913:Dextroamphetamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004597:Electroshock; D000882:Haplorhini; D006801:Humans; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010862:Pilocarpine / Q000494:pharmacology; D012055:Reinforcement Schedule; D012601:Scopolamine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D013566:Sympathomimetics / Q000494:pharmacology*; D013997:Time Factors
D008781:Methyltyrosines; D010277:Parasympathomimetics; D013566:Sympathomimetics; D010862:Pilocarpine; D009020:Morphine; D012601:Scopolamine; D003913:Dextroamphetamine